Literature DB >> 9630070

Implications of genotyping of spouses to limit investigation of children in genetic hemochromatosis.

P C Adams1.   

Abstract

BACKGROUND: A genetic test for hemochromatosis has allowed for the first time, genotypic identification of heterozygotes. The purpose of this study is to determine whether genotyping of spouses of homozygotes results in fewer investigations of children and subsequent cost savings.
METHODS: Two hundred and ninety one children of homozygotes were studied using HLA typing, transferrin saturation and serum ferritin. Ninety six percent of the probands were homozygous for the C282Y mutation of the HFE gene. Pedigrees were reviewed to determine cost savings incurred if the spouse had been genotyped to guide follow-up studies in the children. Paternity was confirmed by HLA studies.
RESULTS: There were 13 homozygotes identified. All homozygous children tested (10/10) were homozygous for the C282Y mutation. There were no iron loaded children identified in homozygotes negative for the C282Y mutation. Genotyping of the spouse eliminated the need for the investigation of 269 children. The cost savings of this strategy were modeled using the cost of the family studies (consultation, iron studies) minus the cost of spouse assessment (consultation, genotyping) plus the cost of assessment of children in families in which the spouse was a heterozygote. The spousal genotyping strategy resulted in a cost savings of 39%.
CONCLUSION: Genotying the spouse of a homozygote is the best cost-efficient strategy in pedigree studies because it leads to more selective investigation of children for the hemochromatosis gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630070     DOI: 10.1111/j.1399-0004.1998.tb02672.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

Review 1.  A diagnostic approach to hemochromatosis.

Authors:  Anthony S Tavill; Paul C Adams
Journal:  Can J Gastroenterol       Date:  2006-08       Impact factor: 3.522

2.  Hemochromatosis: clinical implications of genetic testing.

Authors:  P C Adams
Journal:  CMAJ       Date:  1998-07-28       Impact factor: 8.262

Review 3.  Role of genetic testing and liver biopsy in the diagnosis of hemochromatosis.

Authors:  P C Adams
Journal:  Curr Gastroenterol Rep       Date:  1999 Feb-Mar

4.  Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.

Authors:  Bruce R Bacon; Paul C Adams; Kris V Kowdley; Lawrie W Powell; Anthony S Tavill
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

5.  HFE Gene Mutations and Iron Status in 100 Healthy Polish Children.

Authors:  Barbara Kaczorowska-Hac; Marcin Luszczyk; Jedrzej Antosiewicz; Wieslaw Ziolkowski; Elzbieta Adamkiewicz-Drozynska; Malgorzata Mysliwiec; Ewa Milosz; Jan J Kaczor
Journal:  J Pediatr Hematol Oncol       Date:  2017-07       Impact factor: 1.289

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.